IO Biotech, Inc. IPO Advisory
Share this IPO Profile:Smart Search
Company |
Symbol |
Price Range |
Issue Price |
Open |
Shares |
Trade Date |
| IO Biotech, Inc. | IOBT - NASDAQ |
$14.00-$17.00 | $14.00 | $16.00 | 7.15 million | 11/5/2021 |
| Morgan Stanley, Jefferies, Cowen | ||||||
Co-Manager(s): Kempen & Co. | ||||||
| Health Care | ||||||
Filing(s): Filed 2021-10-15 Terms Added 2021-11-01 | ||||||
IO Biotech, Inc. Quote & Chart - Click for current quote - IOBT
IPO Boutique aggregates information on public companies and private companies, such as "IOBT" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.
About IO Biotech, Inc. (adapted from IO Biotech, Inc. prospectus):
They are a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer therapies based on our T-win technology platform.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
They are a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer therapies based on our T-win technology platform.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
IPO Boutique aggregates information on public companies and private companies, such as "IOBT" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.